Whitehawk Therapeutics, Inc. Financial Flexibility Index
Whitehawk Therapeutics, Inc. financial flexibility index. Whitehawk Therapeutics, Inc. (WHWK) has a Financial Flexibility Index of -1.56x as of September 2025. Free cash flow of $-15.38 Million (operating CF $-15.38 Million minus capex $0.00) represents -2% of total liabilities ($9.85 Million). See WHWK cash flow after capex ratio to measure how efficiently the company converts operating cash flow to free cash.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Whitehawk Therapeutics, Inc. (2019–2024)
Financial flexibility index of Whitehawk Therapeutics, Inc. from 2019 to 2024. Historical Financial Flexibility Index trend for Whitehawk Therapeutics, Inc. across 6 annual periods. Check cash flow quality index of Whitehawk Therapeutics, Inc. to evaluate the quality of earnings relative to operating cash generation.
Whitehawk Therapeutics, Inc. Financial Flexibility Index by Year (2019–2024)
Whitehawk Therapeutics, Inc. financial flexibility index by year from 2019 to 2024. Year-by-year free cash flow to debt coverage for Whitehawk Therapeutics, Inc.. For the full cash flow conversion analysis, see cash efficiency ratio of Whitehawk Therapeutics, Inc..
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -3.25x | $-57.90 Million | $-59.55 Million | $17.84 Million | ▼ -58.7% |
| 2023 | -2.05x | $-55.69 Million | $-59.66 Million | $27.23 Million | ▼ -7.5% |
| 2022 | -1.90x | $-49.20 Million | $-49.64 Million | $25.86 Million | ▼ -82.8% |
| 2021 | -1.04x | $-22.38 Million | $-22.42 Million | $21.50 Million | ▼ -156.1% |
| 2020 | -0.41x | $-12.70 Million | $-12.70 Million | $31.26 Million | ▼ -38.6% |
| 2019 | -0.29x | $-7.55 Million | $-7.58 Million | $25.75 Million | — |